136 related articles for article (PubMed ID: 2947645)
41. Sivelestat reduces inflammatory mediators and preserves neutrophil deformability during simulated extracorporeal circulation.
Matsuzaki K; Hiramatsu Y; Homma S; Sato S; Shigeta O; Sakakibara Y
Ann Thorac Surg; 2005 Aug; 80(2):611-7. PubMed ID: 16039215
[TBL] [Abstract][Full Text] [Related]
42. Serum and plasma measurements of neutrophil granule proteins during cardiopulmonary bypass: a model to estimate human turnover of lactoferrin and myeloperoxidase.
Venge P; Nilsson L; Nyström SO; Aberg T
Eur J Haematol; 1987 Oct; 39(4):339-45. PubMed ID: 2826224
[TBL] [Abstract][Full Text] [Related]
43. Selective kallikrein inhibitors alter human neutrophil elastase release during extracorporeal circulation.
Wachtfogel YT; Hack CE; Nuijens JH; Kettner C; Reilly TM; Knabb RM; Bischoff R; Tschesche H; Wenzel H; Kucich U
Am J Physiol; 1995 Mar; 268(3 Pt 2):H1352-7. PubMed ID: 7535008
[TBL] [Abstract][Full Text] [Related]
44. Release of lactoferrin and elastase in human allergic skin reactions.
Zweiman B; Kucich U; Shalit M; Von Allmen C; Moskovitz A; Weinbaum G; Atkins PC
J Immunol; 1990 May; 144(10):3953-60. PubMed ID: 1692068
[TBL] [Abstract][Full Text] [Related]
45. Angiogenin: a novel inhibitor of neutrophil lactoferrin release during extracorporeal circulation.
Schmaldienst S; Oberpichler A; Tschesche H; Hörl WH
Kidney Blood Press Res; 2003; 26(2):107-12. PubMed ID: 12771535
[TBL] [Abstract][Full Text] [Related]
46. Purified plasma factor XIIa aggregates human neutrophils and causes degranulation.
Wachtfogel YT; Pixley RA; Kucich U; Abrams W; Weinbaum G; Schapira M; Colman RW
Blood; 1986 Jun; 67(6):1731-7. PubMed ID: 3486686
[TBL] [Abstract][Full Text] [Related]
47. Neutrophil degranulation related to the reperfusion of ischemic human heart during cardiopulmonary bypass.
Dhôte-Burger P; Vuilleminot A; Lecompte T; Pasquier C; Bara L; Julia P; Chardigny C; Fabiani JN
J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S124-9. PubMed ID: 8699850
[TBL] [Abstract][Full Text] [Related]
48. Blood compatibility of two different types of membrane oxygenator during cardiopulmonary bypass in infants.
Gu YJ; Boonstra PW; Akkerman C; Mungroop H; Tigchelaar I; Van Oeveren W
Int J Artif Organs; 1994 Oct; 17(10):543-8. PubMed ID: 7896428
[TBL] [Abstract][Full Text] [Related]
49. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment.
Fukutomi M; Kobayashi S; Niwaya K; Hamada Y; Kitamura S
Artif Organs; 1996 Jul; 20(7):767-76. PubMed ID: 8828766
[TBL] [Abstract][Full Text] [Related]
50. Prostacyclin in lieu of anticoagulation with heparin for extracorporeal circulation.
Addonizio VP; Fisher CA; Bowen JC; Palatianos GC; Colman RW; Edmunds LH
Trans Am Soc Artif Intern Organs; 1981; 27():304-7. PubMed ID: 7036500
[TBL] [Abstract][Full Text] [Related]
51. The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation.
Straub A; Wendel HP; Azevedo R; Ziemer G
Eur J Cardiothorac Surg; 2005 Apr; 27(4):617-21. PubMed ID: 15784360
[TBL] [Abstract][Full Text] [Related]
52. Radiographic contrast media and release of neutrophil specific proteins in vitro and after intravenous injection.
Rasmussen F; Antonsen S; Georgsen J; Christensen JK
Acta Radiol; 1992 Sep; 33(5):495-9. PubMed ID: 1389663
[TBL] [Abstract][Full Text] [Related]
53. Influence of temperature on neutrophil trafficking during clinical cardiopulmonary bypass.
Menasché P; Peynet J; Haeffner-Cavaillon N; Carreno MP; de Chaumaray T; Dillisse V; Faris B; Piwnica A; Bloch G; Tedgui A
Circulation; 1995 Nov; 92(9 Suppl):II334-40. PubMed ID: 7586434
[TBL] [Abstract][Full Text] [Related]
54. Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass.
Videm V; Nilsson L; Venge P; Svennevig JL
Artif Organs; 1991 Apr; 15(2):90-5. PubMed ID: 1852153
[TBL] [Abstract][Full Text] [Related]
55. A single dose of granulocyte-macrophage colony-stimulating factor induces systemic interleukin-8 release and neutrophil activation in healthy volunteers.
van Pelt LJ; Huisman MV; Weening RS; von dem Borne AE; Roos D; van Oers RH
Blood; 1996 Jun; 87(12):5305-13. PubMed ID: 8652846
[TBL] [Abstract][Full Text] [Related]
56. The release of beta-thromboglobulin and platelet factor 4 during extracorporeal circulation for open heart surgery.
Cella G; Vittadello O; Gallucci V; Girolami A
Eur J Clin Invest; 1981 Jun; 11(3):165-9. PubMed ID: 6168469
[TBL] [Abstract][Full Text] [Related]
57. Colocalization of elastase and myeloperoxidase in human blood and bone marrow neutrophils using a monoclonal antibody and immunogold.
Cramer EM; Beesley JE; Pulford KA; Breton-Gorius J; Mason DY
Am J Pathol; 1989 Jun; 134(6):1275-84. PubMed ID: 2547320
[TBL] [Abstract][Full Text] [Related]
58. Heparin-coated circuits reduce the formation of TNF alpha during cardiopulmonary bypass.
Yamada H; Kudoh I; Hirose Y; Toyoshima M; Abe H; Kurahashi K
Acta Anaesthesiol Scand; 1996 Mar; 40(3):311-7. PubMed ID: 8721461
[TBL] [Abstract][Full Text] [Related]
59. Extracellular release of antimicrobial defensins by human polymorphonuclear leukocytes.
Ganz T
Infect Immun; 1987 Mar; 55(3):568-71. PubMed ID: 3643886
[TBL] [Abstract][Full Text] [Related]
60. Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation.
van Oeveren W; Kazatchkine MD; Descamps-Latscha B; Maillet F; Fischer E; Carpentier A; Wildevuur CR
J Thorac Cardiovasc Surg; 1985 Jun; 89(6):888-99. PubMed ID: 3158783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
